Accretion Nutraveda Limited (BOM:544694)
345.00
-3.80 (-1.09%)
At close: Nov 16, 2026
Accretion Nutraveda Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 74.64 | 50.68 | 25.01 | 8.22 | 2.81 | - |
Depreciation & Amortization | 2.56 | 2.6 | 2.21 | 2.62 | 3.11 | - |
Other Operating Activities | 2.67 | 0.37 | 3.53 | 2.31 | 1.98 | - |
Change in Accounts Receivable | -52.83 | -48.45 | -30.17 | 5.51 | -2.6 | - |
Change in Inventory | -64.19 | -44.05 | -22.11 | -10.84 | -9.55 | - |
Change in Accounts Payable | -20.09 | -1.41 | 0.01 | -7.61 | 9.36 | - |
Change in Other Net Operating Assets | -16.75 | -53.99 | -0.65 | 2.1 | 1.7 | - |
Operating Cash Flow | -73.99 | -94.25 | -22.16 | 2.3 | 6.81 | - |
Operating Cash Flow Growth | - | - | - | -66.21% | - | - |
Investing Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -116.98 | -60.35 | -8.72 | -1.58 | -0.06 | - |
Investment in Securities | -84.69 | -84.69 | - | - | - | - |
Investing Cash Flow | -201.67 | -145.04 | -8.72 | -1.58 | -0.06 | - |
Financing Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | - | 524.36 | 212.38 | 10.59 | 1.91 | - |
Long-Term Debt Issued | - | 14.89 | 19.3 | - | - | - |
Total Debt Issued | 565.71 | 539.25 | 231.68 | 10.59 | 1.91 | - |
Short-Term Debt Repaid | - | -533.88 | -213.37 | - | - | - |
Long-Term Debt Repaid | - | -1.68 | -1.47 | -8.59 | -6.34 | - |
Total Debt Repaid | -529.49 | -535.56 | -214.83 | -8.59 | -6.34 | - |
Net Debt Issued (Repaid) | 36.21 | 3.7 | 16.85 | 2 | -4.43 | - |
Issuance of Common Stock | 247.68 | 253.53 | 16.51 | - | - | - |
Other Financing Activities | -6.78 | -5.34 | -3.51 | -2.39 | -1.91 | - |
Financing Cash Flow | 277.11 | 251.88 | 29.85 | -0.39 | -6.34 | - |
Net Cash Flow
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | 0 | 0 | - | - | - | - |
Net Cash Flow | 1.45 | 12.6 | -1.04 | 0.33 | 0.42 | - |
Free Cash Flow
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -190.97 | -154.59 | -30.88 | 0.72 | 6.76 | - |
Free Cash Flow Growth | - | - | - | -89.36% | - | - |
Free Cash Flow Margin | -38.98% | -45.99% | -19.30% | 1.42% | 22.51% | - |
Free Cash Flow Per Share | -29.04 | -28.52 | -8.50 | 0.20 | 1.88 | - |
Levered Free Cash Flow | - | -132.86 | -39.28 | -4.42 | 3.71 | - |
Unlevered Free Cash Flow | - | -130.03 | -37.54 | -3.04 | 4.71 | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 6.78 | 5.34 | 3.51 | 2.39 | 1.91 | - |
Cash Income Tax Paid | 19.91 | 16.4 | 6.51 | 1.01 | - | - |
Change in Working Capital | -153.86 | -147.9 | -52.91 | -10.85 | -1.09 | - |